Residualization Rates of Near-Infrared Dyes for the Rational Design of Molecular Imaging Agents

Molecular Imaging and Biology

Volumn 17, Issue 6, 2015, Pages 757-762

  Cilliers, Cornelius ^a   Liao, Jianshan ^a   Atangcho, Lydia ^a   Thurber, Greg M ^a  

^a UNIVERSITY OF MICHIGAN   (United States)

Author keywords

Cyanine dyes; Fluorescently labeled antibodies; Fluorophore retention; Multi modality imaging; Protein metabolism; Receptor internalization

Indexed keywords

BORON DERIVATIVE; BORON DIPYRROMETHENE; CARBOPYRONIN DERIVATIVE; CYANINE DYE; FLUORESCENT DYE; OXAZINE DERIVATIVE; THIAZINE DERIVATIVE; UNCLASSIFIED DRUG;

ARTICLE; ARTIFICIAL MEMBRANE; CONFOCAL MICROSCOPY; FLUORESCENCE IMAGING; IN VIVO STUDY; MEMBRANE PERMEABILITY; MOLECULAR IMAGING; NEAR INFRARED IMAGING SYSTEM; PRIORITY JOURNAL; CELL LINE; CHEMISTRY; HUMAN; NEAR INFRARED SPECTROSCOPY; PROCEDURES;

CELL LINE; FLUORESCENT DYES; HUMANS; MICROSCOPY, CONFOCAL; MOLECULAR IMAGING; SPECTROSCOPY, NEAR-INFRARED;

EID: 84946569926     PISSN: 15361632     EISSN: 18602002     Source Type: Journal    
DOI: 10.1007/s11307-015-0851-7     Document Type: Article

References (25)

1. Brand C, Abdel-Atti D, Zhang Y et al (2014) In vivo imaging of GLP-1R with a targeted bimodal PET/fluorescence imaging agent. Bioconjug Chem 25:1323–1330
2. Kimura RH, Cheng Z, Gambhir SS, Cochran JR (2009) Engineered knottin peptides: a new class of agents for imaging integrin expression in living subjects. Cancer Res 69:2435–2442
3. Seibold U, Wangler B, Schirrmacher R, Wangler C (2014) Bimodal imaging probes for combined PET and OI: recent developments and future directions for hybrid agent development. BioMed Research Int 2014:153741
4. Press OW, Shan D, HowellClark J et al (1996) Comparative metabolism and retention of iodine-125, yttrium-90, and indium-111 radioimmunoconjugates by cancer cells. Cancer Res 56:2123–2129
5. Ferl GZ, Kenanova V, Wu AM, DiStefano JJ (2006) A two-tiered physiologically based model for dually labeled single-chain Fv-Fc antibody fragments. Mol Cancer Ther 5(6):1550–1558
6. Griffiths GL, Govindan SV, Sgouros G et al (1999) Cytotoxicity with Auger electron-emitting radionuclides delivered by antibodies. Int J Cancer J Int Du Cancer 81:985–992
7. Knowles SM, Zettlitz KA, Tavare R et al (2014) Quantitative immunoPET of prostate cancer xenografts with 89Zr- and 124I-labeled anti-PSCA A11 minibody. J Nucl Med Off Publ Soc Nucl Med 55:452–459
8. Hamzei N, Samkoe KS, Elliott JT et al (2014) Comparison of kinetic models for dual-tracer receptor concentration imaging in tumors. Austin J Biomed Eng 1(1)
9. Thurber GM, Wittrup KD (2012) A mechanistic compartmental model for total antibody uptake in tumors. J Theor Biol 314:57–68
10. Williams SP (2012) Tissue distribution studies of protein therapeutics using molecular probes: molecular imaging. AAPS J 14:389–399
11. Bhatnagar S, Deschenes E, Liao J et al (2014) Multichannel imaging to quantify four classes of pharmacokinetic distribution in tumors. J Pharm Sci 103:3276–3286
12. Gioux S, Choi HS, Frangioni JV (2010) Image-guided surgery using invisible near-infrared light: fundamentals of clinical translation. Mol Imaging 9:237–255
13. Laughney AM, Kim E, Sprachman MM et al (2014) Single-cell pharmacokinetic imaging reveals a therapeutic strategy to overcome drug resistance to the microtubule inhibitor eribulin. Sci Transl Med 6:261ra152
14. Thurber GM, Yang KS, Reiner T et al (2013) Single-cell and subcellular pharmacokinetic imaging allows insight into drug action in vivo. Nat Commun 4:1504
15. Thurber GM, Reiner T, Yang KS et al (2014) Effect of small-molecule modification on single-cell pharmacokinetics of PARP inhibitors. Mol Cancer Ther 13:986–995
16. Jose J, Burgess K (2006) Benzophenoxazine-based fluorescent dyes for labeling biomolecules. Tetrahedron 62:11021–11037
17. Kessel D (1990) Photodynamic therapy of neoplastic disease. CRC Press, Inc, Boca Raton
18. Arden-Jacob J, Frantzeskos J, Kemnitzer NU et al (2001) New fluorescent markers for the red region. Spectrochim Acta A Mol Biomol Spectrosc 57:2271–2283
19. Luo FR, Yang Z, Dong H et al (2005) Correlation of pharmacokinetics with the antitumor activity of cetuximab in nude mice bearing the GEO human colon carcinoma xenograft. Cancer Chemother Pharmacol 56:455–464
20. Devaraj NK, Upadhyay R, Hatin JB et al (2009) Fast and sensitive pretargeted labeling of cancer cells through a tetrazine/trans-cyclooctene cycloaddition. Angew Chem Int Ed 48:7013–7016
21. Conner KP, Rock BM, Kwon GK et al (2014) Evaluation of near infrared fluorescent labeling of monoclonal antibodies as a tool for tissue distribution. Drug Metab Dispos Biol Fate Chem 42:1906–1913
22. Yang X, Shi C, Tong R et al (2010) Near IR heptamethine cyanine dye-mediated cancer imaging. Clin Cancer Res Off J Am Assoc Cancer Res 16:2833–2844
23. Shapiro AB, Corder AB, Ling V (1997) P-Glycoprotein-mediated Hoechst 33342 transport out of the lipid bilayer. Eur J Biochem/FEBS 250:115–121
24. Thorpe SR, Baynes JW, Chroneos ZC (1993) The design and application of residualizing labels for studies of protein catabolism. FASEB J 7:399–405
25. Thurber GM, Weissleder R (2011) A systems approach for tumor pharmacokinetics. PLoS One 6(9):e24696